Jaime LaMontagne, Chief Marketing Officer at Astrin Biosciences, shared a post by Astrin Biosciences on LinkedIn, adding:
“Thrilled to welcome this incredible Scientific Advisory Board to Astrin Biosciences.
These leaders have shaped the fields of cancer research, women’s health, radiology, and precision medicine and their partnership strengthens our mission to make early cancer detection more accessible, more actionable, and more widely understood.
Excited for what’s ahead as we prepare to bring Certitude to market.”
Quoting Astrin Biosciences‘s post:
“We are humbled (and thrilled) to announce the formation of our Scientific Advisory Board.
Our new board includes internationally recognized physicians and scientists from Dana-Farber Cancer Institute, George Washington University, Mayo Clinic, Montefiore Einstein Comprehensive Cancer Center, University of Pittsburgh, and Vanderbilt-Ingram Cancer Center.
Welcome, Adrian Lee, Barbara Levy, MD, FACOG, FACS, Ben Ho Park, MD, PhD, Julio Aguirre-Ghiso, Nilay Sethi, Thomas Gilbert, MD, MPP, William Morice II, MD, PhD and Pooja P. Advani, MD.
Read more in our release here.”
You Can Also Read: The First Non-Imaging, Blood-Based Test Designed to Detect Breast Cancer – Astrin Biosciences
